Fidelity National Financial reports Q1 2026 results today with options traders showing the least defensive posture in months — a sharp reversal from the deep hedging seen throughout April.
The most notable shift into this print is in the options market. The put/call ratio has fallen to 1.79, well below its 20-day average of 2.88 and approaching the lower end of the past year's range. In late March and through much of April, the PCR sat between 4.5 and 6.9 — among the highest readings of the past 52 weeks — reflecting heavy demand for downside protection. That hedging has unwound significantly. Whether investors covered those puts after the stock's 12% rebound over the past month, or simply gained confidence into the print, options positioning now looks notably less defensive than it did just weeks ago.
Short interest is a secondary angle here. FNF's SI stands at 3.1% of free float — modest in absolute terms, though it has climbed roughly 32% over the past month in share terms, rising from around 6.4 million to 8.4 million shares short. Borrowing costs paint a benign picture: at just 0.27%, cost to borrow has nearly halved over the past month. Availability remains ample. Together, the lending market signals no meaningful squeeze risk and no concentrated bear trade — the short-side interest reads as hedging rather than conviction.
The analyst debate is less about direction and more about pace. Keefe, Bruyette & Woods trimmed its target from $71 to $67 in early April while holding its Outperform rating, citing macro uncertainty. Barclays similarly cut from $63 to $54 around the same time, maintaining Equal-Weight. Both moves track the broader macro reset that hit rate-sensitive names in early April. The consensus mean target of $64.60 implies around 26% upside to the current price of $51.29 — a meaningful gap for an insurance-adjacent name trading at just 8.4x trailing earnings and with a forward yield of 4.1%. The 12-month forward EPS growth percentile ranks in the 85th percentile, suggesting the Street still sees improving earnings ahead even as near-term estimate momentum — ranked in the 26th percentile on a 30-day basis — has softened.
The past two earnings reactions add a note of caution. The February 2026 print produced a 1-day decline of 5.9% and a 5-day decline of 2.5%. Close peers STC and FAF — both highly correlated title insurers — slid 1.4% and 1.6% respectively over the past week alongside FNF, suggesting sector-level pressure rather than an idiosyncratic FNF story. The Q1 print tests whether the real estate transaction environment has improved enough to justify the stock's month-long recovery, or whether that rally ran ahead of the fundamentals.
See the live data behind this article on ORTEX.
Open FNF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
